Sanofi Opens New Flu Vaccine Facility in Toronto

12:03 PM EDT, 09/16/2026 (MT Newswires) -- Sanofi (SNY) said Wednesday it has opened the Charles Best Building flu vaccine manufacturing facility within the Sanofi Toronto campus that will manufacture its Fluzone High-Dose influenza vaccine. The expansion, which is worth 925 million Canadian dollars ($663.7 million), comprises CA$415 million in partnership from the Government of Canada and CA$55 million from the Government of Ontario. The company said the facility is now fully operational and will start production early next year, pending regulatory approval. Price: 42.89, Change: +0.49, Percent Change: +1.16